Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117–28.
2. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385:1451–61.
3. Herrington WG, Staplin N, Wanner C, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388:117–27.
4. Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383:1413–24.
5. Boehringer Ingelheim Limited. Jardiance 10 mg film-coated tablets. Summary of Product Characteristics, Updated 14 Sep 2023. https://www.medicines.org.uk/emc/product/5441/smpc#about-medicine. Accessed 8 Feb 2024.